Alimta (Eli Lilly and Company)
Welcome to the PulseAid listing for the Alimta drug offered from Eli Lilly and Company. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Pemetrexed disodium |
| SUBSTANCE NAME: | PEMETREXED DISODIUM HEPTAHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-02-04 |
| END MARKETING DATE: | 0000-00-00 |
Alimta HUMAN PRESCRIPTION DRUG Details:
| Item Description | Alimta from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/20mL) |
| START MARKETING DATE: | 2004-02-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-7623_198e5697-bfc8-451c-91fa-e75723963230 |
| PRODUCT NDC: | 0002-7623 |
| APPLICATION NUMBER: | NDA021462 |
Other PEMETREXED DISODIUM HEPTAHYDRATE Pharmaceutical Manufacturers / Labelers:
